Is 89Bio undervalued or overvalued?
As of 2025-03-21, the Intrinsic Value of 89Bio Inc (ETNB) is -12.57 USD. This 89Bio valuation is based on the model Peter Lynch Fair Value. With the current market price of 8.73 USD, the upside of 89Bio Inc is -244.02%. This means that 89Bio is overvalued by 244.02%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.57 - -12.57 | -12.57 | -244.02% |
| P/E | (30.43) - (38.47) | (30.74) | -452.1% |
| DDM - Stable | (22.79) - (63.75) | (43.27) | -595.7% |
| DDM - Multi | (2.68) - (5.83) | (3.67) | -142.0% |
| Market Cap (mil) | 1,274.41 |
| Beta | 1.46 |
| Outstanding shares (mil) | 145.98 |
| Enterprise Value (mil) | 1,184.08 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.64% |
| Cost of Debt | 5.00% |
| WACC | 9.51% |